<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Twenty-nine cases of non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> of low-grade <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> in a European population were investigated for the presence of bcl-2 and bcl-1 gene rearrangement </plain></SENT>
<SENT sid="1" pm="."><plain>The cases were classified according to the Kiel classification </plain></SENT>
<SENT sid="2" pm="."><plain>It was shown that bcl-2 gene rearrangements were exclusively confined to <z:e sem="disease" ids="C1516391" disease_type="Neoplastic Process" abbrv="">centroblastic</z:e>-centrocytic <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>bcl-1 rearrangements were found in two cases of <z:hpo ids='HP_0011010'>chronic</z:hpo> lymphocytic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>As the chromosomal translocation t(14;18) is reported to occur in up to 85% of follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, our results provide additional evidence that the differentiation of low-grade B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> according to the Kiel classification defines biologically distinct entities </plain></SENT>
</text></document>